Last reviewed · How we verify

NCT03569605: IMPACT

Promoting Physical Activity in Young Adult Cancer Survivors Using mHealth and Adaptive Tailored Feedback Strategies

Completed NA Last updated 1 April 2021
What this trial tests

NA trial testing Self-help in Physical Activity in 280 participants. Completed in 29 January 2021.

Timeline
23 August 2018
Primary endpoint
29 January 2021
29 January 2021

Quick facts

Lead sponsorUNC Lineberger Comprehensive Cancer Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment280
Start date23 August 2018
Primary completion29 January 2021
Estimated completion29 January 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

UNC Lineberger Comprehensive Cancer Center — full company profile →

Who can join

Adults 18 to 39, any sex, with Physical Activity or Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To date, few interventions have been designed specifically to promote physical activity in young adult cancer survivors, nor used novel technologies for delivery; none have been successful in promoting long-term adherence to PA. The purpose of this randomized controlled trial is to test the efficacy of a theory-based, mobile physical activity intervention with adaptive goal-setting and tailored feedback that is aimed at increasing physical activity among young adult cancer survivors.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Effect of an mHealth intervention on physical activity outcomes among young adult cancer survivors: The IMPACT randomized controlled trial.
    Valle CG, Diamond MA, Heiling HM, Deal AM, et al · · 2023 · cited 28× · PMID 36444676 · DOI 10.1002/cncr.34556
  2. Recruitment of young adult cancer survivors into a randomized controlled trial of an mHealth physical activity intervention.
    Valle CG, Camp LN, Diamond M, Nezami BT, et al · · 2022 · cited 16× · PMID 35379294 · DOI 10.1186/s13063-022-06148-5
  3. Promoting physical activity in young adult cancer survivors using mHealth and adaptive tailored feedback strategies: Design of the Improving Physical Activity after Cancer Treatment (IMPACT) randomized controlled trial.
    Valle CG, Pinto BM, LaRose JG, Diamond M, et al · · 2021 · cited 15× · PMID 33515784 · DOI 10.1016/j.cct.2021.106293
  4. Physical activity maintenance among young adult cancer survivors in an mHealth intervention: Twelve-month outcomes from the IMPACT randomized controlled trial.
    Valle CG, Diamond MA, Heiling HM, Deal AM, et al · · 2023 · cited 8× · PMID 37317660 · DOI 10.1002/cam4.6238
  5. The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review.
    Foucher J, Azizi L, Öijerstedt L, Kläppe U, et al · · 2024 · cited 1× · PMID 38654383 · DOI 10.1186/s13643-024-02533-0
  6. Disentangling Positive Affect Heterogeneity in a Digital Physical Activity Intervention for Young Adult Cancer Survivors: A Group-Based Multi-Trajectory Modeling Approach.
    Choi SM, Willis EA, Smitherman AB, Martin SL, et al · · 2026 · PMID 42133893 · DOI 10.1002/pon.70484
  7. Examining sociodemographic and health-related characteristics as moderators of an mHealth intervention on physical activity outcomes in young adult cancer survivors.
    Valle CG, Heiling HM, Deal AM, Diamond MA, et al · · 2025 · PMID 38607515 · DOI 10.1007/s11764-024-01577-4

Verify or expand the search:

Other trials of Self-help

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other UNC Lineberger Comprehensive Cancer Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03569605.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing